Month: <span>September 2018</span>

Home / 2018 / September
Post

Mellitus Health and Smart Meter Announce Strategic Partnership for Connected Insulin Titration

TAMPA, Fla. – September 5, 2018 – Mellitus Health, Inc., the developer of Insulin Insights™, the first FDA-cleared and CE-registered clinician decision-support tool for titrating all types of insulin, all eight standard dosing regimens and 125 combinations of insulin, and Smart Meter LLC, an innovative diabetes management technology and solutions company, announced today a strategic...

Post

Genetic testing helps predict disease recurrence in myelodysplastic syndrome

A DNA-based analysis of blood cells soon after a stem cell transplant can predict likelihood of disease recurrence in patients with myelodysplastic syndrome (MDS), a group of cancerous disorders characterized by dysfunctional blood cells, according to new research at Washington University School of Medicine in St. Louis. Such a practice could help doctors identify patients...

Post

An old drug finds new purpose against retinal neovascularization

Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have found that the anti-malaria drug amodiaquine inhibits the apelin receptor protein, which helps drive the vascularization behind diabetic retinopathy, wet age-related macular degeneration (AMD) and other conditions. Because the drug has been approved to treat malaria for decades, it could move relatively quickly through the...

Post

Musical sensor shows bad medicine plays false note

Inspired by a musical instrument, the simple sensor can be constructed from common materials and used to detect adulterated or counterfeit drugs UNIVERSITY OF CALIFORNIA – RIVERSIDE A new sensor based on a 3,000 year old African musical instrument can be used to identify substances, including a poisonous chemical sometimes mistakenly added to medicines. The...

Post

A wearable device for regrowing hair

Although some people embrace the saying “bald is beautiful,” for others, alopecia, or excessive hair loss, can cause stress and anxiety. Some studies have shown that stimulating the skin with lasers can help regrow hair, but the equipment is often large, consumes lots of energy and is difficult to use in daily life. Now, researchers...

Post

Diagnosing and treating resistant hypertension

Resistant hypertension affects 12 percent to 15 percent of patients treated for high blood pressure according to a new scientific statement from the American Heart Association. The statement, published in the Association’s journal Hypertension, provides a comprehensive overview of how to diagnose and treat the condition based on a review of available scientific information. Credit: CC0...

Post

Infectious Theory of Alzheimer’s Disease Draws Fresh Interest

Dr. Leslie Norins is willing to hand over $1 million of his own money to anyone who can clarify something: Is Alzheimer’s disease, the most common form of dementia worldwide, caused by a germ? The search for the cause of Alzheimer’s has so far come up dry. Some researchers are now asking if germs play a role....

Post

Chronic diseases driven by metabolic dysfunction

New model suggests natural healing cycle becomes blocked by cellular miscommunication, allowing conditions like cancer, diabetes and some neurological disorders to persist; a small but dramatic autism trial offers evidence UNIVERSITY OF CALIFORNIA – SAN DIEGO IMAGE: THIS IS A FALSE-COLOR TRANSMISSION ELECTRON MICROGRAPH OF A MITOCHONDRION INSIDE A CELL Much of modern Western medicine is...

Post

Biochemists described a new mechanism for autoimmunity suppression

RUDN biochemists suggested a new mechanism by which the human body prevents the development of autoimmune diseases, allergies, and implant rejection. They report that regulatory T-cells are able to suppress the reproduction of autoimmune cells. The work was published in Molecular Immunology. Plastic plate with a medium for cell growth. Credit: Dmitry Zhdanov The ability of...

Post

A new generation of pain medication

Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medication. The researchers used computer simulations to develop new opioids that will only work at sites affected by injury or inflammation. These drugs can prevent the occurrence of brain- and gut-related side effects typically associated with conventional opioids and have been proven successful...